Also see: Ford, GM, Cabot: Analysts' New Ratings
Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
STOCK COMMENTS / EPS CHANGES
target boosted at Goldman to $82, according to Goldman Sachs. Company is seeing better organic growth across the board. Neutral rating.
estimates, target cut at UBS. NKE estimates were reduced through 2012, UBS said. Company is facing margin pressure. Buy rating and new $90 price target.
estimates, target lowered at Morgan Stanley. Shares of ROVI now seen reaching $59. Estimates also cut, to match the company's new guidance. Equal-weight rating.
estimates cut at ThinkEquity through 2012. Company is investing more in Weibo. Hold rating and $86 price target.
target lowered at Goldman to $23. Investor sentiment is getting weaker in the office retail sector. Neutral rating.
target boosted at JP Morgan to $85. Expect positive data from two ongoing Phase III trials. Overweight rating.
End of report.
This article was written by a staff member of TheStreet.